MedTrace Logo

A Study of MHE in Patients With Liver Diseases

NCT04058327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 252

Last updated 2024-06-17

No results posted yet for this study

Summary

The study analyzes the diagnostic efficacy of neurophysiological tests and blood biomarkers on MHE, predicts risk factors on the development of OHE and investigate the mortality of MHE in patients with cirrhosis and acute on chronic liver failure.

Conditions

  • Hepatic Encephalopathy
  • Minimal Hepatic Encephalopathy
  • Overt Hepatic Encephalopathy

Interventions

DIAGNOSTIC_TEST

neurophysiological tests, blood biomarkers.

Let the patients do neuropsychological tests and detect blood biomarkers.

Sponsors & Collaborators

  • Qin Ning

    lead OTHER

Principal Investigators

  • Qin Ning, MD., PhD. · Department of Infectious Disease, Tongji Hospital, Tongji Medical College, HUST

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04058327 on ClinicalTrials.gov